The Role of Iron and Other Factors in Patients Unresponsive to Erythropoietin Therapy-Reference-Cited by-同舟云学术

The Role of Iron and Other Factors in Patients Unresponsive to Erythropoietin Therapy

Published:2007-10-01 Issue:1 Volume:8 Page:29-34
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:

Author:

Kleiner Morton J.,Wyck David R Van,Kaupke Charles J.,Kirlin Linda R

Publisher

Wiley

Subject

Nephrology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1525-139X.1995.tb00324.x/fullpdf

Reference31 articles.

1. Association between recombi-nant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis;Canadian erythropoietin study group;Br Med J,1990

2. Effect of recombinant human erythropoietin on platelet production in dialysis patients;Kaupke;J Am Soc Nephrol,1993

3. Iron management during recombinant human erythropoietin therapy;Wyck;Am J Kidney Dis,1989

4. Iron deficiency in patients with dialysis-associated anemia during ervthroooietin replacement therapy: Strategies for assessment ana management;Wyck;Semin Nephrol,1989

5. Iron balance in hemodialysis patients;Eschbach;Ann Intern Med,1977

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of recombinant human erythropoietin, vitamin D3and iron therapy on long-term survival of patients with end-stage renal disease receiving haemodialysis: analysis of 702 patients after 10-year follow-up;Public Health Nutrition;2009-04-06

2. l-carnitine treatment of anemia;American Journal of Kidney Diseases;2003-04

3. Iron sucrose: The oldest iron therapy becomes new;American Journal of Kidney Diseases;2002-12

4. Iron deficiency in patients with renal failure;Kidney International;1999-03

5. Prospective evaluation of an anemia treatment algorithm in hemodialysis patients;American Journal of Kidney Diseases;1998-10